197 related articles for article (PubMed ID: 34049594)
1. Protective effect of alamandine on doxorubicin‑induced nephrotoxicity in rats.
Soltani Hekmat A; Chenari A; Alipanah H; Javanmardi K
BMC Pharmacol Toxicol; 2021 May; 22(1):31. PubMed ID: 34049594
[TBL] [Abstract][Full Text] [Related]
2. Protective mechanisms of protocatechuic acid against doxorubicin-induced nephrotoxicity in rat model.
Molehin OR; Adeyanju AA; Adefegha SA; Oyeyemi AO; Idowu KA
J Basic Clin Physiol Pharmacol; 2019 Jul; 30(4):. PubMed ID: 31280244
[TBL] [Abstract][Full Text] [Related]
3. Alamandine significantly reduces doxorubicin-induced cardiotoxicity in rats.
Hekmat AS; Navabi Z; Alipanah H; Javanmardi K
Hum Exp Toxicol; 2021 Oct; 40(10):1781-1795. PubMed ID: 33882726
[TBL] [Abstract][Full Text] [Related]
4. Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats.
Abdel-Raheem IT; Khedr NF
Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):341-53. PubMed ID: 24363042
[TBL] [Abstract][Full Text] [Related]
5. The protective impact of berberine against doxorubicin-induced nephrotoxicity in rats.
Ibrahim Fouad G; Ahmed KA
Tissue Cell; 2021 Dec; 73():101612. PubMed ID: 34371291
[TBL] [Abstract][Full Text] [Related]
6. P-Coumaric Acid Mitigates Doxorubicin-Induced Nephrotoxicity Through Suppression of Oxidative Stress, Inflammation and Apoptosis.
Rafiee Z; Moaiedi MZ; Gorji AV; Mansouri E
Arch Med Res; 2020 Jan; 51(1):32-40. PubMed ID: 32086107
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the protective effect of paricalcitol and vitamin D
Demir F; Demir M; Aygun H
Hum Exp Toxicol; 2021 Feb; 40(2):274-283. PubMed ID: 32812453
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of morin on doxorubicin-induced hepatorenal toxicity in rats.
Kuzu M; Yıldırım S; Kandemir FM; Küçükler S; Çağlayan C; Türk E; Dörtbudak MB
Chem Biol Interact; 2019 Aug; 308():89-100. PubMed ID: 31100273
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of cyclosporine induced nephrotoxicity by dipeptidyl peptidase inhibitor vildagliptin.
Ateyya H
Int Immunopharmacol; 2015 Sep; 28(1):571-7. PubMed ID: 26225924
[TBL] [Abstract][Full Text] [Related]
10. β-Lapachone protects against doxorubicin-induced nephrotoxicity via NAD
Sanajou D; Nazari Soltan Ahmad S; Hosseini V; Kalantary-Charvadeh A; Marandi Y; Roshangar L; Bahrambeigi S; Mesgari-Abbasi M
Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):633-640. PubMed ID: 30671613
[TBL] [Abstract][Full Text] [Related]
11. Protective Effects of Molsidomine Against Cisplatin-Induced Nephrotoxicity.
Karakoc HT; Altintas R; Parlakpinar H; Polat A; Samdanci E; Sagir M; Duran ZR
Adv Clin Exp Med; 2015; 24(4):585-93. PubMed ID: 26469102
[TBL] [Abstract][Full Text] [Related]
12. Thymoquinone attenuates Doxorubicin-induced nephrotoxicity in rats: Role of Nrf2 and NOX4.
Elsherbiny NM; El-Sherbiny M
Chem Biol Interact; 2014 Nov; 223():102-8. PubMed ID: 25268985
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective effect of celecoxib against gentamicin-induced nephrotoxicity through suppressing NFκB and caspase-3 signaling pathways in rats.
Abdelrahman RS; Abdelmageed ME
Chem Biol Interact; 2020 Jan; 315():108863. PubMed ID: 31628940
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of cisplatin-induced nephrotoxicity by statins.
Maheshwari RA; Sailor GU; Patel L; Balaraman R
Indian J Pharmacol; 2013; 45(4):354-8. PubMed ID: 24014910
[TBL] [Abstract][Full Text] [Related]
15. Calcium dobesilate prevents cisplatin-induced nephrotoxicity by modulating oxidative and histopathological changes in mice.
Bazmandegan G; Fatemi I; Kaeidi A; Khademalhosseini M; Fathinejad A; Amirteimoury M
Naunyn Schmiedebergs Arch Pharmacol; 2021 Mar; 394(3):515-521. PubMed ID: 33057778
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of pectin on octylphenol induced kidney dysfunction, oxidative stress and apoptosis in rats.
Koriem KM; Arbid MS; Emam KR
Environ Toxicol Pharmacol; 2014 Jul; 38(1):14-23. PubMed ID: 24860957
[TBL] [Abstract][Full Text] [Related]
17. Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation.
Wu Q; Li W; Zhao J; Sun W; Yang Q; Chen C; Xia P; Zhu J; Zhou Y; Huang G; Yong C; Zheng M; Zhou E; Gao K
Biomed Pharmacother; 2021 May; 137():111308. PubMed ID: 33556877
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation.
Zhang Y; Xu Y; Qi Y; Xu L; Song S; Yin L; Tao X; Zhen Y; Han X; Ma X; Liu K; Peng J
Toxicology; 2017 Mar; 378():53-64. PubMed ID: 28082111
[TBL] [Abstract][Full Text] [Related]
19. Nicorandil combats doxorubicin-induced nephrotoxicity via amendment of TLR4/P38 MAPK/NFκ-B signaling pathway.
Khames A; Khalaf MM; Gad AM; Abd El-Raouf OM; Kandeil MA
Chem Biol Interact; 2019 Sep; 311():108777. PubMed ID: 31376360
[TBL] [Abstract][Full Text] [Related]
20. Lixisenatide protects doxorubicin-induced renal fibrosis by activating wNF-κB/TNF-α and TGF-β/Smad pathways.
Guo NF; Cao YJ; Chen X; Zhang Y; Fan YP; Liu J; Chen XL
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4017-4026. PubMed ID: 31115031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
